Error
  • The template for this display is not available. Please contact a Site administrator.

Hyperparathyroidism, hypophosphatemia & hypercalcemia

doc_thinking

Assessing the Clinical and Laboratory Parameters

 

This scenario is unusual because of the hypophosphatemia – otherwise the pattern is consistent with failing medical management of secondary hyperparathyroidism

 

Less than 1% of all patients are in this category.

 

 

Dialysis Prescription

Dialysis Prescription

Reduction in the dialysate calcium by 0.25-0.50 mmol/L (0.50 – 1.0 mEq/L) may alleviate the hypercalcemia, but will also exacerbate the secondary hyperparathyroidism

 

 

Return to bone and mineral resource home